Different types of molecular anomalies have been identified in gliomas and GBM, such as loss of CDKN2A, RB1, and TP53 tumor suppressor genes, in addition to mutations in the genes involved in these pathways or regulated by these tumor suppressor proteins [16,18,19,20,21,22]. The gene discussed is TP53; the disease is glioblastoma.